Neurology & Neurovascular

Health Canada Approves NeuroCatch™ Brain Assessment System

No comments
Health Canada Approves NeuroCatch™ Brain Assessment System

Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure NeuroCatch, Inc. has recently announced the approval of their NeuroCatch™ Platform for a medical device license as Canada’s first objective and rapid neuro-physiological brain function assessment system. The device assesses neurological function through the measurement of event-related

iData ResearchHealth Canada Approves NeuroCatch™ Brain Assessment System
read more

Brain Tumor Extracting Device Deemed FDA Breakthrough Device

No comments
Brain Tumor Extracting Device Deemed FDA Breakthrough Device

Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure A new approach to brain cancer treatment has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device designation, which denotes that with no approved products with similar capabilities, the FDA will expedite the device’s development in

iData ResearchBrain Tumor Extracting Device Deemed FDA Breakthrough Device
read more

Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

No comments
Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

Register to receive a free Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE Mark approval for the TIGERTRIEVER 13. In addition, first patients have been treated successfully with the device.

iData ResearchRapid Medical Receives CE Mark Approval for TIGERTRIEVER 13
read more

FDA Expands Treatment Window for Use of the Trevo Clot Retrieval Device In Certain Stroke Patients

No comments
FDA Expands Treatment Window for Use of the Trevo Clot Retrieval Device In Certain Stroke Patients

Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure The U.S. Food and Drug Administration today cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device’s indication to a broader group of

iData ResearchFDA Expands Treatment Window for Use of the Trevo Clot Retrieval Device In Certain Stroke Patients
read more

Phoenix Children’s Hospital is the First in Arizona to Offer New FDA Approved Epilepsy Treatment by LivaNova

No comments
Phoenix Children’s Hospital is the First in Arizona to Offer New FDA Approved Epilepsy Treatment by LivaNova

The latest Vagus Nerve Stimulation Therapy® (“VNS Therapy”) System through LivaNova PLC features the recently FDA-approved SenTiva™ implantable generator, the smallest and lightest responsive therapy for epilepsy.

iData ResearchPhoenix Children’s Hospital is the First in Arizona to Offer New FDA Approved Epilepsy Treatment by LivaNova
read more